Related Experiment Video
Updated: Feb 26, 2026
07:54
Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence
Published on: October 25, 2011
19.3K
Tumor Heterogeneity in Lymphomas: A Different Breed
Christian M Schürch1, Birgit Federmann, Leticia Quintanilla-Martinez
1Institute of Pathology and Neuropathology, University Hospital Tübingen, Tübingen, Germany.
Summary
Cancer
Area of Science:
- Pathology
- Oncology
- Genetics
Background:
- Cancer is a complex disease characterized by heterogeneous cell populations.
- Tumor heterogeneity significantly impacts clinical behavior and treatment response.
- Precision medicine necessitates a deeper understanding of tumor diversity.
Purpose of the Study:
- To review tumor heterogeneity in lymphomas from a pathologist's perspective.
- To explore the interplay of morphologic, immunophenotypic, and genetic heterogeneity.
- To discuss the clinical and therapeutic implications of lymphoma heterogeneity.
Main Methods:
- Review of existing literature on tumor heterogeneity in lymphomas.
- Analysis of morphologic, immunophenotypic, and genetic data.
- Discussion of driving factors and clinical relevance.
Main Results:
- Lymphoma exhibits significant intertumoral and intratumoral heterogeneity.
- Heterogeneity arises from genomic instability, epigenetic changes, microenvironment, and stochastic variations.
- Mechanisms include subclonal evolution, leading to spatial variation and treatment resistance.
Conclusions:
- Understanding lymphoma heterogeneity is crucial for personalized treatment strategies.
- Morphologic, immunophenotypic, and genetic analyses are key to characterizing heterogeneity.
- Addressing heterogeneity drivers can improve therapeutic outcomes in lymphoma patients.
Related Concept Videos
02:07Tumor Progression
7.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.5K
02:40Cancer Stem Cells and Tumor Maintenance
6.1K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
6.1K
02:21Cancers Originate from Somatic Mutations in a Single Cell
15.1K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
15.1K
02:17The Tumor Microenvironment
8.0K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.0K
01:18Lymphoid Cells and Tissues
3.5K
Lymphoid cells and tissues are integral to the immune system, which is crucial in maintaining our body's defense against harmful pathogens. They form the building blocks of lymphoid organs, which include the spleen, thymus, and lymph nodes.
Lymphoid cells consist of various types of immune system cells. These include B and T lymphocytes, which are responsible for producing antibodies and killing infected cells, respectively. Dendritic cells act as messengers between the innate and adaptive...
Lymphoid cells consist of various types of immune system cells. These include B and T lymphocytes, which are responsible for producing antibodies and killing infected cells, respectively. Dendritic cells act as messengers between the innate and adaptive...
3.5K
01:27Tumor Immunotherapy
2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K